Back to Search
Start Over
Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria
- Source :
- PLoS Neglected Tropical Diseases, PLoS Neglected Tropical Diseases, Vol 15, Iss 7, p e0009610 (2021)
- Publication Year :
- 2021
- Publisher :
- Public Library of Science (PLoS), 2021.
-
Abstract
- Background Plasmodium vivax occurs as a latent infection of liver and a patent infection of red blood cells. Radical cure requires both blood schizontocidal and hypnozoitocidal chemotherapies. The hypnozoitocidal therapies available are primaquine and tafenoquine, 8-aminoquinoline drugs that can provoke threatening acute hemolytic anemia in patients having an X-linked G6PD-deficiency. Heterozygous females may screen as G6PD-normal prior to radical cure and go on to experience hemolytic crisis. Methods & findings This study examined G6PD phenotypes in 1928 female subjects living in malarious Sumba Island in eastern Indonesia to ascertain the prevalence of females vulnerable to diagnostic misclassification as G6PD-normal. All 367 (19%) females having<br />Author summary Plasmodium vivax causes patent infection of red blood cells and latent infection of the liver. Radical cure for malaria effectively kills parasites in both blood and liver stages. Currently, radical cure for malaria involves either primaquine or tafenoquine, both of which cause acute hemolytic anemia in patients with an inherited defect in G6PD enzymatic activity. G6PD deficiency is an X-linked disorder and it is the most common enzyme deficiency in humans. Heterozygous females having one mutated and one normal gene may screen as G6PD normal in qualitative enzyme activity screening prior to primaquine therapy and be at risk of proceeding to hemolytic crisis. To date, there is no evidence-based G6PD activity cut-off value to distinguish those females who may not safely receive primaquine. This study aimed to inform this cut-off by a large survey of females by quantitative G6PD activity phenotyping along with genotyping of the G6PD gene. Two thousand females residing in a meso-endemic area in eastern Indonesia were screened for G6PD deficiency using qualitative and quantitative tests. Those with
- Subjects :
- Hemolytic anemia
Plasmodium
Heredity
Primaquine
Tafenoquine
Epidemiology
Physiology
RC955-962
Plasmodium vivax
Compound heterozygosity
Homozygosity
chemistry.chemical_compound
Medical Conditions
0302 clinical medicine
Genotype-phenotype distinction
Arctic medicine. Tropical medicine
hemic and lymphatic diseases
Medicine and Health Sciences
030212 general & internal medicine
Child
Glucose-6-Phosphate Dehydrogenase Deficiency
Aged, 80 and over
education.field_of_study
Heterozygosity
biology
Drugs
Anemia
Hematology
Body Fluids
Blood
Infectious Diseases
Female
Public aspects of medicine
RA1-1270
Anatomy
Research Article
medicine.drug
Adult
congenital, hereditary, and neonatal diseases and abnormalities
medicine.medical_specialty
Adolescent
030231 tropical medicine
Population
Glucosephosphate Dehydrogenase
Gene Expression Regulation, Enzymologic
Antimalarials
Young Adult
03 medical and health sciences
Internal medicine
Parasite Groups
parasitic diseases
Malaria, Vivax
Genetics
Parasitic Diseases
medicine
Humans
Genetic Predisposition to Disease
education
Aged
Pharmacology
business.industry
Hemolytic Anemia
Public Health, Environmental and Occupational Health
nutritional and metabolic diseases
Biology and Life Sciences
Tropical Diseases
medicine.disease
biology.organism_classification
Malaria
chemistry
Indonesia
Medical Risk Factors
Latent Infection
Parasitology
business
Apicomplexa
Subjects
Details
- ISSN :
- 19352735
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- PLOS Neglected Tropical Diseases
- Accession number :
- edsair.doi.dedup.....3b4009aa27e8be5dcd6185281244344b